{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:00:32Z","timestamp":1740160832529,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13346-021-01082-6","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T21:08:49Z","timestamp":1634764129000},"page":"1738-1752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liposomal formulations of oxybutynin and resiniferatoxin for the treatment of urinary diseases: improvement of drug tolerance upon intravesical"],"prefix":"10.1007","volume":"12","author":[{"given":"Lorena M. D.","family":"Cirino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daviane M. C.","family":"Vergne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle B.","family":"Novais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine F.","family":"Padilha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Severino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo L. C.","family":"de Albuquerque J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana C.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-6017","authenticated-orcid":false,"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"1082_CR1","doi-asserted-by":"crossref","unstructured":"D'Ancona C, Haylen B, Oelke M, Abranches\u2010Monteiro L, Arnold E, Goldman H et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433\u201377.","DOI":"10.1002\/nau.23897"},{"key":"1082_CR2","doi-asserted-by":"crossref","unstructured":"Alla MF, Mahmoud MA, Youssef AE-RSJ. Safety and efficacy of intermittent versus continuous anticholinergic medication in management of overactive bladder in adult. Egyp J Hosp Med. 2018;70(2).","DOI":"10.12816\/0043080"},{"issue":"4","key":"1082_CR3","first-page":"256","volume":"11","author":"M Honda","year":"2019","unstructured":"Honda M, Kimura Y, Tsounapi P, Hikita K, Saito M, Takenaka AJ. Long-term efficacy, safety, and tolerability of modified intravesical oxybutynin chloride for neurogenic bladder in children. J Clin Med Res\u00a02019;11(4):256.","journal-title":"Long-term efficacy, safety, and tolerability of modified intravesical oxybutynin chloride for neurogenic bladder in children"},{"key":"1082_CR4","doi-asserted-by":"crossref","unstructured":"Kajbafzadeh A-M, Ahmadi H, Montaser-Kouhsari L, Sabetkish S, Ladi-Seyedian S, Sotoudeh MJT. Intravesical electromotive administration of botulinum toxin type A in improving the bladder and bowel functions: Evidence for novel mechanism of action. J Spinal Cord Med. 2019:1\u20137.","DOI":"10.1080\/10790268.2019.1603490"},{"issue":"1","key":"1082_CR5","first-page":"5795","volume":"8","author":"W-C Lee","year":"2018","unstructured":"Lee W-C, Su C-H, Tain Y-L, Tsai C-N, Yu C-C. Chuang Y-CJ. Potential orphan drug therapy of intravesical liposomal onabotulinumtoxin-A for ketamine-induced cystitis by mucosal protection and anti-inflammation in a rat model. Sci. Rep. 2018;8(1):5795.","journal-title":"Potential orphan drug therapy of intravesical liposomal onabotulinumtoxin-A for ketamine-induced cystitis by mucosal protection and anti-inflammation in a rat model"},{"key":"1082_CR6","doi-asserted-by":"crossref","unstructured":"Dalsgaard T, Str\u00f8b\u00e6k D, Christophersen PJ. KV7. 2\u20137.5 Channel-activation contributes to bladder relaxation induced by oxybutynin or mirabegron. The FASEB J. 2018;32(1_supplement):567.7-.7.","DOI":"10.1096\/fasebj.2018.32.1_supplement.567.7"},{"key":"1082_CR7","doi-asserted-by":"crossref","unstructured":"Andersson K-EJ. Agents in early development for treatment of bladder dysfunction-promise of drugs acting at TRP channels?  Expert Opin Investig Drugs 2019;28(9):749-755.","DOI":"10.1080\/13543784.2019.1654994"},{"key":"1082_CR8","doi-asserted-by":"crossref","unstructured":"Oliveira R, Coelho A, Franquinho F, Sousa MM, Cruz F, D. Cruz CJN et al. Effects of early intravesical administration of resiniferatoxin to spinal cord\u2010injured rats in neurogenic detrusor overactivity. Neurourol Urodyn. 2019;38(6):1540-1550.","DOI":"10.1002\/nau.24032"},{"key":"1082_CR9","doi-asserted-by":"publisher","unstructured":"Corcos J, Przydacz M. Incontinence due to neurogenic detrusor overactivity. in: \"Consultation in Neurourology - A Practical Evidence-Based Guide\". Springer; 2018. p. 77\u2013113; https:\/\/doi.org\/10.1007\/978-3-319-63910-9.","DOI":"10.1007\/978-3-319-63910-9"},{"issue":"4","key":"1082_CR10","first-page":"519","volume":"33","author":"P Tyagi","year":"2006","unstructured":"Tyagi P, Tyagi S, Kaufman J, Huang L, de Miguel F. Local drug delivery to bladder using technology innovations. Urol Clin North Am\u00a02006;33(4):519\u201330.","journal-title":"Local drug delivery to bladder using technology innovations"},{"key":"1082_CR11","doi-asserted-by":"crossref","unstructured":"Severino P, Moraes LF, Zanchetta B, Souto EB, Santana MH. Elastic liposomes containing benzophenone-3 for sun protection factor enhancement. Pharm Dev Technol. 2012;17(6):661\u20135.","DOI":"10.3109\/10837450.2011.580762"},{"key":"1082_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.colsurfb.2018.07.049","volume":"171","author":"TN Pashirova","year":"2018","unstructured":"Pashirova TN, Zueva IV, Petrov KA, Lukashenko SS, Nizameev IR, Kulik NV, et al. Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model. Colloids Surf B Biointerfaces. 2018;171:358\u201367. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.07.049.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1082_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2017.07.001","volume":"68","author":"MC Teixeira","year":"2017","unstructured":"Teixeira MC, Carbone C, Souto EB. Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble\/poorly permeable drug delivery. Prog Lipid Res. 2017;68:1\u201311. https:\/\/doi.org\/10.1016\/j.plipres.2017.07.001.","journal-title":"Prog Lipid Res"},{"key":"1082_CR14","doi-asserted-by":"crossref","unstructured":"Purves JT. Intravesical drug therapy. in: \"Neurourology - Theory and Practice\".  Liao, Limin, Madersbacher, Helmut (Eds.), Springer; 2019. p. 277\u20139.","DOI":"10.1007\/978-94-017-7509-0_30"},{"issue":"1","key":"1082_CR15","first-page":"64","volume":"26","author":"SA Rizvi","year":"2018","unstructured":"Rizvi SA. Saleh AMJ. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J. 2018;26(1):64\u201370.","journal-title":"Applications of nanoparticle systems in drug delivery technology"},{"issue":"5","key":"1082_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3109\/1040841X.2015.1028885","volume":"42","author":"AJ Carey","year":"2016","unstructured":"Carey AJ, Tan CK, Ipe DS, Sullivan MJ, Cripps AW, Schembri MA, et al. Urinary tract infection of mice to model human disease: practicalities, implications and limitations. Crit Rev Microbiol. 2016;42(5):780\u201399. https:\/\/doi.org\/10.3109\/1040841X.2015.1028885.","journal-title":"Crit Rev Microbiol"},{"issue":"2","key":"1082_CR17","first-page":"147","volume":"103","author":"W Zschiesche","year":"1995","unstructured":"Zschiesche W, Kleine AH, Spitzer E, Veerkamp JH, Glatz JF. Histochemical localization of heart-type fatty-acid binding protein in human and murine tissues. Histochem Cell Biol. 1995;103(2):147\u201356.","journal-title":"Histochemical localization of heart-type fatty-acid binding protein in human and murine tissues"},{"key":"1082_CR18","first-page":"6249","volume":"14","author":"HY Yoon","year":"2019","unstructured":"Yoon HY, Chang IH, Goo YT, Kim CH, Kang TH, Kim S-Y, et al. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel Int J. Nanomedicine 2019;14:6249.","journal-title":"Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel"},{"key":"1082_CR19","doi-asserted-by":"crossref","unstructured":"Singh P, Bodycomb J, Travers B, Tatarkiewicz K, Travers S, Matyas GR et al. Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technology. Int J Pharm. 2019;566:680-686.","DOI":"10.1016\/j.ijpharm.2019.06.013"},{"key":"1082_CR20","doi-asserted-by":"crossref","unstructured":"Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol. 2006;50(6):1299\u2013305.","DOI":"10.1016\/j.eururo.2006.04.006"},{"issue":"4","key":"1082_CR21","first-page":"355","volume":"88","author":"C Silva","year":"2001","unstructured":"Silva C, Avelino A, Souto-Moura C. Cruz F. A light-and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application. BJU Int. 2001;88(4):355\u201360.","journal-title":"A light-and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application"},{"issue":"8","key":"1082_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00192-012-1682-6","volume":"23","author":"MA Banakhar","year":"2012","unstructured":"Banakhar MA, Al-Shaiji TF, Hassouna MM. Pathophysiology of overactive bladder. Int Urogynecol J. 2012;23(8):975\u201382. https:\/\/doi.org\/10.1007\/s00192-012-1682-6.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"1082_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.bjp.0705399","volume":"140","author":"KE Read","year":"2003","unstructured":"Read KE, Sanger GJ, Ramage AG. Evidence for the involvement of central 5-HT7 receptors in the micturition reflex in anaesthetized female rats. Br J Pharmacol. 2003;140(1):53\u201360. https:\/\/doi.org\/10.1038\/sj.bjp.0705399.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1082_CR24","first-page":"53","volume":"30","author":"PC Palma","year":"2004","unstructured":"Palma PC, Thiel M, Riccetto CL, Dambros M, Miyaoka R. Netto Jr NR. Resiniferatoxin for detrusor instability refractory to anticholinergics. Int Braz J Urol. 2004;30(1):53\u20138.","journal-title":"Resiniferatoxin for detrusor instability refractory to anticholinergics"},{"key":"1082_CR25","unstructured":"Fraser MO, Lavelle JP, Sacks MS, Chancellor MB. The future of bladder control\u2014intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol. 2002;4(1):1."},{"issue":"4","key":"1082_CR26","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","volume":"182","author":"YC Chuang","year":"2009","unstructured":"Chuang YC, Lee WC, Lee WC, Chiang PH. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome. J Urol. 2009;182(4):1393\u2013400. https:\/\/doi.org\/10.1016\/j.juro.2009.06.024.","journal-title":"J Urol"},{"issue":"1","key":"1082_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urols.2014.12.008","volume":"26","author":"S-Y Hung","year":"2015","unstructured":"Hung S-Y, Chancellor DD, Chancellor MB, Chuang Y-C. Role of liposome in treatment of overactive bladder and interstitial cystitis. Urological Science. 2015;26(1):3\u20136. https:\/\/doi.org\/10.1016\/j.urols.2014.12.008.","journal-title":"Urological Science"},{"key":"1082_CR28","doi-asserted-by":"crossref","unstructured":"Kim D-Y, Chancellor MB. Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder. J Endourol. 2000;14(1):97\u2013103.","DOI":"10.1089\/end.2000.14.97"},{"issue":"1","key":"1082_CR29","first-page":"70","volume":"393","author":"L Men\u00e9ndez","year":"2006","unstructured":"Men\u00e9ndez L, Ju\u00e1rez L, Garc\u00eda E, Garc\u00eda-Su\u00e1rez O, Hidalgo A, Baamonde A. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett. 2006;393(1):70\u20133.","journal-title":"Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice"},{"issue":"1","key":"1082_CR30","first-page":"3","volume":"4","author":"JK Neubert","year":"2008","unstructured":"Neubert JK, Mannes AJ, Karai LJ, Jenkins AC, Zawatski L, Abu-Asab M, et al. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain. 2008;4(1):3.","journal-title":"Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia"},{"key":"1082_CR31","doi-asserted-by":"crossref","unstructured":"Szallasi A, Blumberg PM, Lundberg JM. Proton inhibition of [3H] resiniferatoxin binding to vanilloid (capsaicin) receptors in rat spinal cord. Eur J Pharmacol. 1995;289(2):181\u20137.","DOI":"10.1016\/0922-4106(95)90093-4"},{"issue":"1","key":"1082_CR32","first-page":"359","volume":"179","author":"C Saitoh","year":"2008","unstructured":"Saitoh C, Chancellor MB, De Groat WC, Yoshimura N. Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats. J Urol. 2008;179(1):359\u201364.","journal-title":"Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats"},{"key":"1082_CR33","doi-asserted-by":"crossref","unstructured":"Shenfeld OZ, Meir KS, Yutkin V, Gofrit ON, Landau EH, Pode DJU. Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? Urology, 2005;65(1):181\u20134.","DOI":"10.1016\/j.urology.2004.08.055"},{"key":"1082_CR34","doi-asserted-by":"crossref","unstructured":"Reis LO, Sopena JMG, F\u00e1varo WJ, Martin MC, Sim\u00e3o AFL, Reis RBd et al. Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool. Acta Cir\u00fargica Brasileira. 2011;26:106\u201310.","DOI":"10.1590\/S0102-86502011000800019"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-01082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-01082-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-01082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T14:54:00Z","timestamp":1653576840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-01082-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-01082-6","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"type":"print","value":"2190-393X"},{"type":"electronic","value":"2190-3948"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"12 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics issues are raised as part of the work performed in animals. The protocol for the animal experimentation (Protocol no. 060208) has been approved by the Research Ethics Committee of Tiradentes University through the Consubstantiated Opinion and by the Ethics Committee (CETEA) of the Federal University of Minas Gerais, Brazil, for anesthesia in small animals, in compliance with national and European regulations (in particular, the EU Directive 2010\/63\/EU and the 3Rs policy for the use of animals in scientific research).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}